Investing

Top Analyst Upgrades and Downgrades: Berkshire Hathaway, CarMax, Noble, Phillips 66, Portola Pharma, Qualcomm and More

Agnico-Eagle Mines Ltd. (NYSE: AEM) was downgraded to Neutral from Buy at UBS.

Atwood Oceanics Inc. (NYSE: ATW) was downgraded to Underweight from Equal Weight and the price target was cut to $6 from $7 (versus an $8.43 close) at Barclays.

BB&T Corp. (NYSE: BBT) was downgraded to Underweight from Neutral with a $35 price target (versus a $33.69 close) at Piper Jaffray.

CF Industries Holdings Inc. (NYSE: CF) was downgraded to Neutral from Overweight and the price target was cut to $34 from $40 (versus a $31.94 close) at Piper Jaffray.

CIT Group Inc. (NYSE: CIT) was downgraded to Neutral from Buy and the price target was cut to $37 from $40 (versus a $33.46 close) at Sterne Agee CRT.

Corcept Therapeutics Inc. (NASDAQ: CORT) was reiterated as Buy with a $8.00 fair value estimate (versus a $4.29 close) at Janney Montgomery Scott. The call is ahead of important data expected at ASCO from a rare profitable small biotech, with expectations for broad utility of selective glucocorticoid receptor inhibition.

Dollar General Corp. (NYSE: DG) was reiterated as Buy and the price target was raised to $97 from $96 at Jefferies.


ENSCO International PLC (NYSE: ESV) was downgraded to Negative from Neutral with an $8 price target (versus a $10.60 close) at Susquehanna.

Finish Line Inc. (NASDAQ: FINL) was reiterated as Buy and the price target was raised to $24 from $22 at Jefferies.

Goldcorp Inc. (NYSE: GG) was downgraded to Neutral from Buy at UBS.

H.B. Fuller Co. (NYSE: FUL) was raised to Overweight from Neutral and the price target was raised to $46 from $37 at JPMorgan.

KBR Inc. (NYSE: KBR) was raised to Neutral from Sell at Goldman Sachs.

Performance Sports Group Ltd. (NYSE: PSG) was downgraded to Underperform from Neutral at Bank of America Merrill Lynch.

SPX Corp. (NYSE: SPXC) was started as Outperform and the price target was put at $17 at Credit Suisse.